including infection at the injection site, a dislodged IV catheter, and a collapsed vein. The administration of intravenous fluids is common and safe. However, speak with a healthcare professional ...

The European Commission (EC) has approved the new subcutaneous (SC) formulation of Bristol Myers Squibb’s (BMS) Opdivo ...

Administrating life-saving drugs for cardiac arrest directly into the bone does not improve survival rates compared to the standard intravenous (IV) method, according to new research from The ...

for subcutaneous pembrolizumab administered with chemotherapy with a median injection time of two minutes, versus intravenous (IV) KEYTRUDA ® (pembrolizumab) administered with chemotherapy for ...

Notably, this interview came following the Dec. 27, 2024, Food and Drug Administration (FDA) approval of the subcutaneous injection formulation of Opdivo for patients with solid tumors. Intravenous ...